Search Within

Genitourinary Oncology Service

  1. "Elsevier Inc."
Formats
  1. Journal Article (244)
  2. Meeting Abstract (117)
  3. Review (7)
  4. Conference Paper (6)
  5. Book Section (3)
  6. Editorial (2)
  7. Guidelines (1)
Groups
  1. Solid Tumor Oncology Division (380)
  2. Department of Medicine (379)
  3. GSK Faculty (91)
  4. Surgery (67)
  5. Survivorship Research (62)
  6. Urology (55)

More Groups

People
  1. Robert Motzer (89)
  2. Howard Scher (72)
  3. Dean Bajorin (51)
  4. Jonathan Rosenberg (40)
  5. David Solit (31)
  6. Gopakumar Iyer (31)

More People

Years
  1. 2025 (12)
  2. 2024 (29)
  3. 2023 (10)
  4. 2022 (17)
  5. 2021 (11)
  6. 2020 (9)

More Years

Publications
  1. European Journal of Cancer (96)
  2. Clinical Genitourinary Cancer (63)
  3. Urologic Oncology: Seminars and Original Investigations (50)
  4. International Journal of Radiation Oncology, Biology, Physics (47)
  5. Seminars in Oncology (41)
  6. Hematology/Oncology Clinics of North America (10)

More Publications

Publishers
  1. Elsevier Inc. (380)

Results (380)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Re-analysis of intravesical gemcitabine in the era of Bacillus Calmette-Guérin (BCG)-unresponsive non–muscle-invasive bladder cancer
    Journal Article

    De Jesus Escano, M. R.; Vertosick, E. A.; D'Souza, N.; Benfante, N.; Lenis, A. T.; Reisz, P. A.; Gaffney, C.; Goh, A.; Donahue, T. F.; Cha, E.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • SPINK1 immunohistochemistry: An ancillary tool to diagnose urothelial carcinoma in situ and urothelial dysplasia
    Journal Article

    Khani, F.; Beg, S.; Park, K.; Kawaguchi, K.; Chiu, Y. L.; Robinson, B. D.; Lis, R.; Stack, E. C.; Scherr, D. S.; Rosenberg, J. E.; more...
    Pathology Research and Practice (2025)

    Fulltext@MSK | Save
  • Germline landscape of high grade serous ovarian cancer across age groups: Is age just a number?
    Journal Article

    Sia, T. Y.; Moufarrij, S.; Milani, J.; Kane, S.; Zhou, Q.; Fong, C.; Khurram, A.; Kemel, Y. M.; Sheehan, M.; Latham, A.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Off-label use of first-line immunotherapy for metastatic renal cell carcinoma
    Journal Article

    McManus, H. D.; Long, J. B.; Westvold, S. J.; Leapman, M. S.; Hurwitz, M. E.; Mitchell, A. P.; Pollack, C. E.; Gross, C. P.; Dinan, M. A.
    Clinical Genitourinary Cancer (2025)

    Fulltext@MSK | Save
  • Clinical and genomic characterization of a single-center cohort of renal cell carcinoma patients with KRAS mutation
    Meeting Abstract

    Sanmiguel, A. L.; Hakimi, A. A.; Khandwala, Y.; Calderon, L. P.; Dawidek, M.; Chen, Y. B.; Russo, P.; Coleman, J.; Carlo, M.
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Correlative science from a phase I study of intravesical Fc-optimized anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guerin (BCG)
    Meeting Abstract

    Bochner, B. H.; Alam, S. M.; Blanchard, L.; Yao, N.; Angulo-Lozano, J.; Wong, J.; Knorr, D.; Whiting, K.; Seshan, V.; Donahue, T.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • A phase 1B trial of masofaniten (EPI-7386) in patients with metastatic castration-resistant prostate cancer (MCRPC)
    Meeting Abstract

    Laccetti, A.; Iannotti, N.; Pachynski, R.; Carthon, B.; Chi, K. N.; Smith, M.; Saad, F.; Pili, R.; Tu, W.; Kwan, E. M.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Transcriptional analysis of bladder cancer histologic subtypes reveals novel drug target heterogeneity
    Meeting Abstract

    Tallman, J. E.; Kuo, F.; Koll, F.; Alam, S. M.; Basar, M.; Luo, J.; Gao, S. P.; Tang, X.; Yol, C.; Gokturk, G.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Gene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitors
    Journal Article

    Khaleel, S.; Perera, M.; Papa, N.; Kuo, F.; Golkaram, M.; Rappold, P.; Kotecha, R. R.; Coleman, J.; Russo, P.; Motzer, R.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Impact of postprogression therapies on overall survival: Recommendations from the 2023 Kidney Cancer Association think tank meeting
    Review

    Berg, S. A.; La Rosa, S.; Zhang, T.; Pierorazio, P. M.; Albiges, L.; Beckermann, K. E.; Campbell, M. T.; Carlo, M. I.; Coleman, K.; George, D. J.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save